Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Blood
|
October 9, 1998
Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected
J F Tisdale, A K Stewart, B Dickstein, et al.
Human Gene Therapy
|
March 27, 1999
No discrepancy between in vivo gene marking efficiency assessed in peripheral blood populations compared with bone marrow progenitors or CD34+ cells
S E Sellers, J F Tisdale, D M Bodine, et al.
Bone Marrow Transplantation
|
April 23, 2013
Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model
C D Fitzhugh, R P Weitzel, M M Hsieh, et al.
British Journal of Haematology
|
January 29, 2000
Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia
N Giri, E Kang, J F Tisdale, et al.
Lancet (London, England)
|
November 15, 2000
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial
J F Tisdale, D E Dunn, N Geller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 10, 2000
Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods
T Wu, H J Kim, S E Sellers, et al.
Gene Therapy
|
November 22, 2013
Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model
N Uchida, R P Weitzel, M E Evans, et al.
Rheumatology (Oxford, England)
|
February 24, 2007
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis
G G Illei, C H Yarboro, T Kuroiwa, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 28, 2010
Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating
S Perl, J A Kushner, B A Buchholz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 10, 2000
Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model
D A Heim, Y Hanazono, N Giri, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Blood
|
October 9, 1998
Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected
J F Tisdale, A K Stewart, B Dickstein, et al.
Human Gene Therapy
|
March 27, 1999
No discrepancy between in vivo gene marking efficiency assessed in peripheral blood populations compared with bone marrow progenitors or CD34+ cells
S E Sellers, J F Tisdale, D M Bodine, et al.
Bone Marrow Transplantation
|
April 23, 2013
Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model
C D Fitzhugh, R P Weitzel, M M Hsieh, et al.
British Journal of Haematology
|
January 29, 2000
Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia
N Giri, E Kang, J F Tisdale, et al.
Lancet (London, England)
|
November 15, 2000
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial
J F Tisdale, D E Dunn, N Geller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 10, 2000
Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods
T Wu, H J Kim, S E Sellers, et al.
Gene Therapy
|
November 22, 2013
Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model
N Uchida, R P Weitzel, M E Evans, et al.
Rheumatology (Oxford, England)
|
February 24, 2007
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis
G G Illei, C H Yarboro, T Kuroiwa, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 28, 2010
Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating
S Perl, J A Kushner, B A Buchholz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 10, 2000
Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model
D A Heim, Y Hanazono, N Giri, et al.
Page
of 4